SB Technology

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, SB Technology sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed upper quartile by trial count

SB Technology: 3 sponsored US clinical trials, 1 recruiting.

SB Technology sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is ACS (Acute Coronary Syndrome), with 1 trials.

Upper-quartile sponsor footprint

SB Technology sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

A Prospective Research Investigation of Ischemia Using MCG

NCT06481943
COMPLETED NA

Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin

NCT06620744
COMPLETED NA

MCG Discovery Study in Emergency Departments

NCT06095557

Therapeutic Areas

ACS (Acute Coronary Syndrome) 1
NSTEMI - Non-ST Segment Elevation MI 1
Acute Coronary Syndrome 1

What is open in the SB Technology pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: ACS (Acute Coronary Syndrome) (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

SB Technology: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

SB Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share SB Technology10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
SB Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

SB Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this SB Technology page

3 registered trials is a research-attention snapshot, not an endorsement of SB Technology or any single study.

  • 1 of SB Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • ACS (Acute Coronary Syndrome) is the condition SB Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See ACS (Acute Coronary Syndrome) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

SB Technology pipeline card: 3 registered trials from official public datasets.Report a data error.